HETEROCYCLIC COMPOUND

The present invention provides a compound having a superior JAK inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases (rheumatoid arthritis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, sys...

Full description

Saved in:
Bibliographic Details
Main Authors DAINI MASAKI, KAMEI TAKU, KIKUCHI FUMIAKI, NARA HIROSHI, KAIEDA AKIRA, IMAEDA TOSHIHIRO
Format Patent
LanguageEnglish
Published 21.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a compound having a superior JAK inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases (rheumatoid arthritis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus, etc.), cancer (leukemia, uterine leiomyosarcoma, prostate cancer, multiple myeloma, cachexia, myelofibrosis, etc.) and the like, or a salt thereof. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
Bibliography:Application Number: US201314404126